Latest Breaking News On - Monique allaire - Page 6 : comparemela.com

Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer

Auron Establishes Premier Scientific Advisory Board to Support the Advancement of its AI-Powered Platform and Pipeline Targeting Cellular Plasticity in Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMassachusetts institute of technologyDana farber cancer instituteProvence alpes côd azurUnited kingdomFrance generalRichard chesworthMikhail misha roshalCharlesm rudinShin san michael suVander heidenLaurence joseph dineenMatthew vander heidenSylvia hassenfeldEytanm steinTed williams

ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis

ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRichard lowenthalLaura oneillMonique allaireJustin chakmaDrug administrationPharmaceuticals incWhile the agencyExchange commissionEuropean medicines agencyAllergy drug advisory committeeStrategic communicationsAdditional time neededPost marketing requirements discussionsPrescription drug user fee actNew drug application

Anokion SA: Anokion Announces Publication in The Lancet Gastroenterology & Hepatology Highlighting Safety and Preliminary Effects of KAN-101 in Celiac Disease in its ACeD Phase 1 Clinical Trial

Anokion SA: Anokion Announces Publication in The Lancet Gastroenterology & Hepatology Highlighting Safety and Preliminary Effects of KAN-101 in Celiac Disease in its ACeD Phase 1 Clinical Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Deborah geraghtyMonique allaireStrategic communicationsLancet gastroenterology hepatologyCeliac disease

ARS Pharmaceuticals Announces Availability of Briefing

SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company dedicated to empowering at-risk.

United statesArielle bernstein pinsofRichard lowenthalMonique allaireExchange commissionDrug administrationStrategic communicationsPharmaceuticals incDrugs advisory committeeAllergy drugs advisory committeeChief executive officerPrescription drug user fee actTypei allergic reactionsPrivate securities litigation reform actNasdaq spryArs pharmaceuticals

Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors

Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Monique allaireMichael wyzgaAshish nimgaonkarGensight biologicsStrategic communicationsConsulting incAkebia therapeutics incOncomed pharmaceuticals incGenzyme corporationIdenix pharmaceuticals incProvidence collegeMereo biopharma groupJohns hopkins universityInvivyd incSuffolk universityBoard of directors radius health inc